Analytical performance evaluation of a multiplex real-time RT-PCR kit for simultaneous detection of SARS-CoV-2, influenza A/B, and RSV
PeerJ · 2025
DOI: 10.7717/peerj.19693 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Chi-Sheng Tai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Medical Science, National Defense Medical Center, Taipei City, Taiwan. Hauptthemen laut MEDLINE: SARS-CoV-2, Influenza, Human, Respiratory Syncytial Virus Infections, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tri-Service General Hospital, Taipei.
Abstract (Originalsprache)
Differentiating between influenza, respiratory syncytial virus (RSV), and SARS-CoV-2 based on clinical symptoms alone can be challenging due to their overlap. This cross-sectional study, conducted from September to November 2023, evaluated the analytic performance of the LabTurbo multiplex real-time reverse transcription polymerase chain reaction (RT-PCR) kit for the simultaneous detection of these viruses. Nasopharyngeal swab specimens were tested using the LabTurbo kit, the Cobas Liat SARS-CoV-2 influenza A/B assay, and the Cobas influenza A/B and RSV assays. RNA standards were serially diluted and tested with the LabTurbo kit to determine the limit of detection (LOD). This cross-sectional study involved the analysis of 350 nasopharyngeal swab samples, which included 250 positive cases (50 cases each of influenza A, influenza B, and RSV, along with 100 cases of SARS-CoV-2) and 100 negative cases. The LabTurbo kit demonstrated 100% positive percent agreement and negative percent agreement with the reference assays for detecting SARS-CoV-2, influenza A/B, and RSV. The LODs for SARS-CoV-2, influenza A, influenza B, and RSV were 8,333, 3,333, 6,667, and 8,333 copies/mL, respectively. These findings confirm the diagnostic accuracy and analytic performance of the LabTurbo multiplex real-time RT-PCR kit for the detection of SARS-CoV-2, influenza A/B, and RSV, simultaneously. This assay could substantially improve the rapid identification and differentiation of these pathogens, thereby enabling more timely and appropriate treatment measures to control the spread of co-circulating viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate Institute of Medical Science, National Defense Medical Center, Taipei City, Taiwan.
- Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei city, Taiwan.
Förderung
- Tri-Service General Hospital, Taipei
Zitieren
APA
Tai, C. S., Jian, M. J., Lin, T. H., Chung, H. Y., Chang, C. K., Perng, C. L., Hsieh, P. S., & Shang, H. S. (2025). Analytical performance evaluation of a multiplex real-time RT-PCR kit for simultaneous detection of SARS-CoV-2, influenza A/B, and RSV. PeerJ. https://doi.org/10.7717/peerj.19693
Vancouver
Tai CS, Jian MJ, Lin TH, Chung HY, Chang CK, Perng CL, et al. Analytical performance evaluation of a multiplex real-time RT-PCR kit for simultaneous detection of SARS-CoV-2, influenza A/B, and RSV. PeerJ. 2025. doi:10.7717/peerj.19693
BibTeX
@article{Tai2025,
author = {Tai, Chi-Sheng and Jian, Ming-Jr and Lin, Tai-Han and Chung, Hsing-Yi and Chang, Chih-Kai and Perng, Cherng-Lih and Hsieh, Po-Shiuan and Shang, Hung-Sheng},
title = {Analytical performance evaluation of a multiplex real-time RT-PCR kit for simultaneous detection of SARS-CoV-2, influenza A/B, and RSV},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.19693}
}
EUVIMED